28131783|t|Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron
28131783|a|Cannabinoid system is a potential target for pain control. Cannabinoid receptor 1 (CB1) activation play a role in the analgesic effect of cannabinoids once it is expressed in primary afferent neurons. This study investigates whether the anti-hyperalgesic effect of CB1 receptor activation involves P2X3 receptor in primary afferent neurons. Mechanical hyperalgesia was evaluated by electronic von Frey test. Cannabinoid effect was evaluated using anandamide or ACEA, a non-selective or a selective CB1 receptor agonists, respectively; AM251, a CB1 receptor antagonist, and antisense ODN for CB1 receptor. Calcium imaging assay was performed to evaluated α,β-meATP - responsive cultured DRG neurons pretreated with ACEA. Anandamide or ACEA administered in peripheral tissue reduced the carrageenan -induced mechanical hyperalgesia. The reduction in the carrageenan -induced hyperalgesia induced by ACEA was completely reversed by administration of AM251 as well as by the intrathecal treatment with antisense ODN for CB1 receptor. Also, ACEA reduced the mechanical hyperalgesia induced by bradykinin and by α,β-meATP, a P2X3 receptor non-selective agonist, but not by tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and chemokine -induced chemoattractant-1 (CINC-1). Finally, CB1 receptor s are co-localized with P2X3 receptors in DRG small-diameter neurons and the treatment with ACEA reduced the number of α,β-meATP - responsive cultured DRG neurons. Our data suggest that the analgesic effect of CB1 receptor activation is mediated by a negative modulation of the P2X3 receptor in the primary afferent neurons.
28131783	0	23	Antihyperalgesic effect	T033	UMLS:C0243095
28131783	27	39	CB1 receptor	T103	UMLS:C0378126
28131783	40	50	activation	T038	UMLS:C1514758
28131783	78	91	P2X3 receptor	T103	UMLS:C0382265
28131783	116	122	neuron	T017	UMLS:C0027882
28131783	123	141	Cannabinoid system	T103	UMLS:C0006864
28131783	168	180	pain control	T058	UMLS:C1304888
28131783	182	204	Cannabinoid receptor 1	T103	UMLS:C0378126
28131783	206	209	CB1	T103	UMLS:C0378126
28131783	241	257	analgesic effect	T033	UMLS:C0948482
28131783	261	273	cannabinoids	T103	UMLS:C0006864
28131783	315	322	neurons	T017	UMLS:C0027882
28131783	388	400	CB1 receptor	T103	UMLS:C0378126
28131783	455	462	neurons	T017	UMLS:C0027882
28131783	464	487	Mechanical hyperalgesia	T033	UMLS:C2936719
28131783	505	529	electronic von Frey test	T058	UMLS:C0430022
28131783	531	542	Cannabinoid	T103	UMLS:C0006864
28131783	570	580	anandamide	T103	UMLS:C0211726
28131783	584	588	ACEA	T103	UMLS:C0767833
28131783	621	642	CB1 receptor agonists	T103	UMLS:C1720260
28131783	658	663	AM251	T103	UMLS:C0534009
28131783	667	690	CB1 receptor antagonist	T103	UMLS:C2927149
28131783	696	709	antisense ODN	T103	UMLS:C0079925
28131783	714	726	CB1 receptor	T103	UMLS:C0378126
28131783	728	735	Calcium	T103	UMLS:C0006675
28131783	736	749	imaging assay	T058	UMLS:C0079595
28131783	777	786	α,β-meATP	T103	UMLS:C0051285
28131783	809	812	DRG	T017	UMLS:C0017070
28131783	813	820	neurons	T017	UMLS:C0027882
28131783	837	841	ACEA	T103	UMLS:C0767833
28131783	843	853	Anandamide	T103	UMLS:C0211726
28131783	857	861	ACEA	T103	UMLS:C0767833
28131783	908	919	carrageenan	T103	UMLS:C0007289
28131783	929	952	mechanical hyperalgesia	T033	UMLS:C2936719
28131783	975	986	carrageenan	T103	UMLS:C0007289
28131783	996	1008	hyperalgesia	T033	UMLS:C2936719
28131783	1020	1024	ACEA	T103	UMLS:C0767833
28131783	1070	1075	AM251	T103	UMLS:C0534009
28131783	1121	1134	antisense ODN	T103	UMLS:C0079925
28131783	1139	1151	CB1 receptor	T103	UMLS:C0378126
28131783	1159	1163	ACEA	T103	UMLS:C0767833
28131783	1176	1199	mechanical hyperalgesia	T033	UMLS:C2936719
28131783	1229	1238	α,β-meATP	T103	UMLS:C0051285
28131783	1242	1255	P2X3 receptor	T103	UMLS:C0382265
28131783	1270	1277	agonist	T103	UMLS:C1720260
28131783	1290	1317	tumor necrosis factor alpha	T103	UMLS:C1456820
28131783	1319	1324	TNF-α	T103	UMLS:C1456820
28131783	1327	1345	interleukin-1 beta	T103	UMLS:C0021753
28131783	1347	1352	IL-1β	T103	UMLS:C0021753
28131783	1358	1367	chemokine	T103	UMLS:C0282554
28131783	1377	1394	chemoattractant-1	T103	UMLS:C0033684
28131783	1396	1402	CINC-1	T103	UMLS:C0033684
28131783	1414	1426	CB1 receptor	T103	UMLS:C0378126
28131783	1451	1465	P2X3 receptors	T103	UMLS:C0382265
28131783	1469	1472	DRG	T017	UMLS:C0017070
28131783	1488	1495	neurons	T017	UMLS:C0027882
28131783	1519	1523	ACEA	T103	UMLS:C0767833
28131783	1546	1555	α,β-meATP	T103	UMLS:C0051285
28131783	1578	1581	DRG	T017	UMLS:C0017070
28131783	1582	1589	neurons	T017	UMLS:C0027882
28131783	1617	1633	analgesic effect	T033	UMLS:C0948482
28131783	1637	1649	CB1 receptor	T103	UMLS:C0378126
28131783	1650	1660	activation	T038	UMLS:C1514758
28131783	1705	1718	P2X3 receptor	T103	UMLS:C0382265
28131783	1743	1750	neurons	T017	UMLS:C0027882